ADARx Pharmaceuticals, Inc. Common Stock

ADRXNASDAQ • USD
13.93 USD
↘ 0.07 (0.50%)🟢LIVE (AS OF 01:06 PM EST)
🟢Market: OPEN

Shares of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) are trading at $13.93. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$14.03
High?$14.87
Low?$13.02
Prev. Close?$14.00
Volume?381.0K
Avg. Volume?N/A
VWAP?$13.85
Bid / Ask
Bid?$11.73 × 100
Ask?$15.82 × 100
Spread?$4.09
Midpoint?$13.78
Valuation & Ratios
Market Cap?1.6B
Shares Out?N/A
Float?52.5M
Float %?49.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
Employees
N/A
Market Cap
1.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-09-25
Address
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA 92121
Phone: 858-283-9472
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?3.43%Low
Short Interest?1.8M
Days to Cover?5.0
Free Float52.5M
Avg Daily Volume358.5K
Settlement Date2026-10-30